GENNEX LABORATORIES
|
The Current P/S Ratio of GENNEX LABORATORIES is 3.65.
Share Price | ₹18.7 | Jan 03,2025 |
Market Cap | ₹425.5 Cr | |
Sales-TTM | ₹116.6 Cr | TTM-Consolidated Results |
Price/Sales | 3.65x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of GENNEX LABORATORIES
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹425.5 Cr] as on Jan 03,2025
(/) Sales [ ₹116.6 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 3.65x ]
Thus, for GENNEX LABORATORIES , the investors are currently willing to pay '3.65 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of GENNEX LABORATORIES !
The chart below summarizes the trend in P/S Ratio of GENNEX LABORATORIES over the last five years.
Historical PS (Price/Sales) ratio chart of GENNEX LABORATORIES
PS Ratio Performance Analysis for GENNEX LABORATORIES
- GENNEX LABORATORIES 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 1.69x.
- GENNEX LABORATORIES 's operated at median p/e ratio of 1.51x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, GENNEX LABORATORIES 's p/e ratio peaked in Mar2024 at 4.14x.
- GENNEX LABORATORIES 's p/e ratio hit its five-year low in Mar2020 of 0.42x.
How does GENNEX LABORATORIES 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
GENNEX LABORATORIES | 116.6 | 3.65 | 425.5 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 50,307.7 | 8.82 | 443,661.0 |
CIPLA LTD | 26,512.0 | 4.60 | 121,970.0 |
DR REDDYS LABORATORIES LTD | 30,084.9 | 3.75 | 112,877.0 |
ZYDUS LIFESCIENCES LTD | 21,483.5 | 4.57 | 98,163.2 |
DIVIS LABORATORIES LTD | 8,614.0 | 18.63 | 160,496.0 |
MANKIND PHARMA LTD | 11,018.0 | 11.00 | 121,222.0 |
TORRENT PHARMACEUTICALS LTD | 11,225.0 | 10.25 | 115,071.0 |
LUPIN LTD | 21,431.3 | 5.04 | 108,030.0 |
AUROBINDO PHARMA LTD | 30,295.0 | 2.53 | 76,628.1 |
ABBOTT INDIA LTD | 6,066.1 | 10.32 | 62,629.8 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs GENNEX LABORATORIES 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 2.53x |
Max industry PS | 18.63x |
Median industry PS | 5.04x |
Average industry PS | 7.56x |
You may also like the below Video Courses